Phase II trial of the epothilone analog sagopilone (ZK219477; ZK EPO) in patients with recurrent glioblastoma: Initial report of the EORTC study 26061
Article
Stupp, R., Tosoni, A., Taal, W., Hau, P., Campone, M., Gijtenbeek, J., Frenay, M. P., Gorlia, T., Lacombe, D. and Brandes, A. A. (2008) Phase II trial of the epothilone analog sagopilone (ZK219477; ZK EPO) in patients with recurrent glioblastoma: Initial report of the EORTC study 26061. Journal of Clinical Oncology 26 (15_sup), p. 2015.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Clinical Oncology | ||||
| Publisher | AMER SOC CLINICAL ONCOLOGY | ||||
| Place of Publication | ALEXANDRIA | ||||
| Volume | 26 | ||||
| Number of Issue or Book Chapter | 15_sup | ||||
| Page Range | p. 2015 | ||||
| Date | 2008 | ||||
| Date of publication | 19 Dec 2024 13:19 | ||||
| Institutions | Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT) | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 68134 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric